Hypocholesterolemic and hypoglycemic effects of enzymatically modified carbohydrates from rice in high-fat-fed C57BL/6J mice

Molecular Nutrition and Food Research

Volumn 55, Issue SUPPL. 2, 2011, Pages

  Bhuiyan, Muhammad J H ^a   Do, Ha Viet ^b   Mun, Saehun ^b   Jun, Hee jin ^a   Lee, Ji Hae ^a   Kim, Yong Ro ^b   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Bile acid excretion; Cholesterol; Glucose metabolism; Lipid metabolism; Rice starch

Indexed keywords

4 ALPHA GLUCANOTRANSFERASE; 4 ALPHA-GLUCANOTRANSFERASE; ADENYLATE KINASE; ADIPONECTIN; ANTIDIABETIC AGENT; BILE ACID; CARBOHYDRATE; CELL RECEPTOR; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CYTOCHROME P450 7A1, MOUSE; FARNESOID X RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15, MOUSE; GLYCOGEN DEBRANCHING ENZYME; HYPOCHOLESTEROLEMIC AGENT; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; STARCH;

ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; DIETARY FIBER; DRUG EFFECT; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; RICE; SECRETION;

ADENYLATE KINASE; ADIPONECTIN; ANIMALS; ANTICHOLESTEREMIC AGENTS; BILE ACIDS AND SALTS; BLOOD GLUCOSE; BODY WEIGHT; CARBOHYDRATES; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DIET, HIGH-FAT; DIETARY FIBER; FIBROBLAST GROWTH FACTORS; GLUCOSE TOLERANCE TEST; GLYCOGEN DEBRANCHING ENZYME SYSTEM; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; ORYZA SATIVA; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, LDL; STARCH;

MUS;

EID: 80053265218     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100121     Document Type: Article

References (52)

1. Kromhout, D., Epidemiology of cardiovascular diseases in Europe. Public Health Nutr. 2001, 4, 441-457.
2. Kennel, W. B., Castelli, W. P., Gordon, T., Cholesterol in the prediction of atherosclerotic disease. 1979. New perspectives based on the Framingham study. Ann. Intern. Med. 1979, 90, 85-91.
3. Kaplan, N. M., The deadly quartet. Upper-body, obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 1989, 149, 1514-1520.
4. Zimmet, P., Albert, K. G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 2001, 414, 782-787.
5. Kumar, V., Nelso, F., Abbas, A. (Eds.), Pathologic Basis of Disease, Saunders, UK 2004, pp. 1194-1195.
6. Alan, R. S., Ronald, C. K., Insulin signaling and the regulation of glucose and lipid metabolism. Nature 2001, 414, 799-806.
7. Rudermann, N. B., Gupta, S., Sussman, I., (Eds.), Hyperglycemia, Diabetes and Vascular Disease: an Overview, Oxford University Press, New York 1990, pp. 3-20.
8. Lora, K. R., Morse, K. L., Gonzalez-Kruger, G. E., Driskell, J. A., High saturated fat and cholesterol intakes and abnormal plasma lipid concentrations observed in a group of 4- to 8-year old children of Latino immigrants in rural Nebraska. Nutr. Res. 2007, 27, 483-491.
9. Jimenez, J. P., Serrano, J., Tabernero, M., Arranz, S. et al., Effects of grape antioxidant dietary fiber in cardiovascular disease risk factors. Nutrition 2008, 24, 646-653.
10. Theuwissen, E., Mensink, R. P., Water-soluble dietary fibers and cardiovascular disease. Physiol. Behav. 2008, 94, 285-292.
11. David, E. K., Sugars and starch in the nutritional management of diabetes mellitus. Am. J. Clin. Nutr. 2003, 78, 858S-864S.
12. Simin, L., Meir, J. S., Frank, B. H., Edward, G., Whole grain consumption and risk of coronary heart disease: results from the Nurses' Health study. Am. J. Clin. Nutr. 1999, 70, 412-419.
13. Jukka, M., Paul, K., Ritva, J., Arpo, A., Antti, R., Whole-grain and fiber intake and the incidence of type 2 diabetes. Am. J. Clin. Nutr. 2003, 77, 622-627.
14. Denis, L., Nathalie, A., Sandrine, B., Richard, P. et al., Dietary fiber intake and risk factors for cardiovascular disease in French adults. Am. J. Clin. Nutr. 2005, 82, 1185-1194.
15. Anderson, J. W., Randles, K. M., Kendall, C. W. C., Jenking, D. J. A., Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J. Am. Coll. Nutr. 2004, 23, 5-17.
16. Brown, L., Rosner, B., Willett, W. W., Sacks, F. M., Cholesterol-lowering effects of dietary fiber: a meta analysis. Am. J. Clin. Nutr. 1999, 69, 30-42.
17. Anderson, J. W., Tietyen-Clark, J., Dietary fiber: heperlipidemia, hypertension, and coronary heart disease. Am. J. Gastroenterol. 1986, 81, 907-919.
18. Slavin, J. L., Martini, M. C., Jacobs, J., Marquart, L., Plausible mechanisms for the protectiveness of whole grains. Am. J. Clin. Nutr. 1999, 70, 459S-463S.
19. Mustapha, B., Karen, A. K. M., Bruce, R. H., Rice amylopectin fine structure variability affects starch digestion properties. J. Agr. Food Chem. 2007, 55, 1475-1479.
20. Kaper, T., Maarel-van der, M. J. E. C., Euverink, G. J. W., Dijkkhuizen, L., Exploring and exploiting starch-modifying amylomaltases from thermophiles. Biochem. Soc. T. 2004, 32, 279-282.
21. Chang, K. L., Quang, T. L., Yung, H. K., Jae, H. S. et al., Enzymatic synthesis and properties of highly branched rice starch amylose and amylopectin cluster. J. Agric. Food Chem. 2008, 56, 126-131.
22. Park, J. H., Kim, H. J., Kim, Y. H., Cha, H. J. et al., The action mode of Thermus aquaticus YT-1, 4-α-glucanotransferase and its chimeric enzymes introduced with starch-binding domain on amylase and amylopectin. Carbohyd. Polym. 2007, 67, 164-173.
23. Liebl, W., Feil, R., Gabelsberger, J., kellermann, J., Schleifer, K. H., Purification and characterization of a novel thermostable 4-α-glucanotransferase of Thermotoga maritima cloned in Escherichia coli. Eur. J. Biochem. 1992, 207, 81-88.
24. Bradford, M., A rapid and sensitive method for the quantitative of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
25. Sodhi, N. S., Singh, N., Morphological, thermal and rheological properties of starches separated from rice cultivars grown in India. Food Chem. 2003, 80, 99-108.
26. Gidley, M. J., Quantification of the structural features of starch polysaccharides by NMR spectroscopy. Carbohyd. Res. 1985, 139, 85-93.
27. Fausa, O., Skålhegg, B. A., Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3-hydroxysteroid dehydrogenase. Scand. J. Gastroenterol. 1974, 9, 249-254.
28. Zhang, L., Perdomo, G., Kim, D. H., Qu, S. et al., Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism 2008, 57, 1115-1124.
29. Bjorck, I., Granfeldt, Y., Liljeberg, H., Tovar, J., Asp, N. G., Food properties affecting the digestion and absorption of carbohydrates. Am. J. Clin. Nutr. 1994, 59, 699S-705S.
30. Ludwig, D. S., The glycemic index: physiological mechanisms relating to obesity, diabetes and cardiovascular disease. J. Am. Med. Assoc. 2002, 287, 2414-2423.
31. Rendell, M. S., Jovanovic, L., Targeting postprandial hyperglycemia. Metab. Clin. Exper. 2006, 55, 1263-1281.
32. Reaven, G. M., Brand, R. J., Chen, Y. D., Mathur, A. K., Goldfine, I., Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 1993, 42, 1324-1332.
33. Giorda, C., Appendino, M., Effects of doxazosin, a selective alpha-1 inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism 1993, 42, 1440-1442.
34. Diez, J. J., Iglesias, P., The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur. J. Endocrinol. 2003, 148, 293-300.
35. Ukkola, O., Santaniemi, M., Adiponectin: a link between excess adiposity and associated comorbidities? J. Mol. Med. 2002, 80, 696-702.
36. Pajvani, U. B., Scherer, P. E., Adiponectin: systemic contributor to insulin sensitivity. Curr. Diab. Rep. 2003, 3, 207-213.
37. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H. et al., Diet induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8, 731-737.
38. Waki, H., Yamauchi, T., Kamon, J., Ito, Y. et al., Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J. Biol. Chem. 2003, 278, 40352-40362.
39. Considine, R. V., Sinha, M. K., Heiman, M. L., Aidas, K. et al., Serum immunoreactive-leptin concentrations in normal-weight and obese human. N. Engl. J. Med. 1996, 334, 292-295.
40. Grover, S. A., Levington, C., Paquet, S., Identifying adults at low risk for significant hyperlipidemia: a validated climatic index. J. Clin. Epidemiol. 1999, 52, 49-55.
41. Frohlich, J., Dobiasova, M., Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin. Chem. 2003, 49, 1873-1880.
42. Goldstein, J. L., Brown, M. S., Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc. Natl. Acad. Sci. USA 1979, 76, 3330-3337.
43. Hardie, D. G., Carling, D., Carlson, M., The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem. 1998, 67, 821-855.
44. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y. et al., Adiponectin stimulate glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8, 1288-1295.
45. Danielsson, H., Techen, T. T., Greenberg, D. M., (Eds.), Steroid Metabolism, Academic Press Inc., New York 1968, p. 117.
46. Agellon, L. B., Vance, D. E., Vance, J. E., (Eds.), Metabolism and Function of Bile Acids, Elsevier, Amsterdam 2002, pp. 433-448.
47. Inagaki, T., Choi, M., Moschetta, A., Peng, L. et al., Fibroblast growth factor FGF-15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005, 2, 217-225.
48. Holt, J. A., Luo, G., Billin, A. N., Bisi, J. et al., Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 2003, 17, 1581-1591.
49. Hagenbuch, B., Dawson, P., The sodium bile salt cotransport family SLC10. Pflugers Arch. 2004, 447, 566-570.
50. Jaleel, F., Jaleel, A., Rahman, M. A., Alam, E., Comparison of adiponectin, leptin and blood lipid levels in normal and obese postmenopausal women. J. Pak. Med. Assoc. 2006. 56, 391-394.
51. Nadler, S. T., Stoehr, J. P., Schueler, K. L., Tanimoto, G. et al., The expression of adipogenic gene is decreased in obesity and diabetes mellitus. Proc. Natl. Acad. Sci. USA 2001, 97, 11371-11376.
52. Simonen, P., Gylling, H., Howard, A., Miettinen, T. A., Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am. J. Clin. Nutr. 2000, 72, 82-88.